EUVIMEDEUVIMED entdecken
Systematische ÜbersichtLeitlinie

Prevention of pre‐eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence

Kiran Ninan, Rifaa Ali, Frederick Morfaw, Sarah D McDonald iD

International Journal of Gynecology & Obstetrics · 2023-04 · 161 (1) · 26-39

DOI: 10.1002/ijgo.14471 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Gynecology & Obstetrics, 2022-10. Verfasst von Kiran Ninan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Pre-Eclampsia, Perinatal Death. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence has shown significant benefits of aspirin for preventing pre‐eclampsia.

Objectives

The objective of this study was to systematically review recommendations from clinical practice guidelines and other recommendation documents on aspirin for the prevention of pre‐eclampsia. Search strategy Ten databases were searched for statements from December 1, 2013, to January 1, 2022. Selection criteria Without language restrictions, the most recent version of documents was considered. Data collection and analysis Two authors independently extracted recommendations. Guideline quality was assessed using a modified AGREE‐II instrument and the AGREE‐REX tool. Main results Out of 48 statements on the prevention of pre‐eclampsia, 46 had recommendations on use of aspirin. Of them, 39 were supported by evidence from systematic reviews or randomized controlled trials. Three statements reported aspirin's significant reductions in preterm pre‐eclampsia and one in perinatal death. Concerning quality, 41% of statements were rated as high quality in all domains of the AGREE‐II tool, 15% were rated high quality in all domains of the AGREE‐REX tool, and 11% were rated high quality in all domains on both tools.

Conclusions

While 96% of statements advocated for use of aspirin, only 9% reported a significant reduction in preterm pre‐eclampsia or perinatal death. Based on the AGREE tools, future statements could use methodological improvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPerinatal DeathPregnancyFemaleInfant, NewbornHumansAspirin

Stichwörter der Autor:innen

aspirinpre-eclampsiapregnancy-induced hypertensionsystematic review

Substanzen

Aspirin

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada.
  • Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Division of Maternal-Fetal Medicine, McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: Sarah D McDonald

Zitieren

APA

Ninan, K., Ali, R., Morfaw, F., & McDonald, S. D. (2023). Prevention of pre‐eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence. International Journal of Gynecology & Obstetrics, 161(1), 26-39. https://doi.org/10.1002/ijgo.14471

Vancouver

Ninan K, Ali R, Morfaw F, McDonald SD. Prevention of pre‐eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence. International Journal of Gynecology & Obstetrics. 2023;161(1):26-39. doi:10.1002/ijgo.14471

BibTeX
@article{Ninan2023,
  author = {Ninan, Kiran and Ali, Rifaa and Morfaw, Frederick and McDonald, Sarah D},
  title = {Prevention of pre‐eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2023},
  volume = {161},
  number = {1},
  pages = {26--39},
  doi = {10.1002/ijgo.14471}
}
Kostenlos starten →